[go: up one dir, main page]

CN111265392B - Amblyopia treatment system - Google Patents

Amblyopia treatment system Download PDF

Info

Publication number
CN111265392B
CN111265392B CN202010125073.9A CN202010125073A CN111265392B CN 111265392 B CN111265392 B CN 111265392B CN 202010125073 A CN202010125073 A CN 202010125073A CN 111265392 B CN111265392 B CN 111265392B
Authority
CN
China
Prior art keywords
amblyopia
treatment
module
patient
therapeutic apparatus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010125073.9A
Other languages
Chinese (zh)
Other versions
CN111265392A (en
Inventor
顾根秋
严大思
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongjingkang (Guangxi) Medical Device Technology Co.,Ltd.
Original Assignee
Shenzhen Vision Intelligent Manufacturing Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Vision Intelligent Manufacturing Technology Co ltd filed Critical Shenzhen Vision Intelligent Manufacturing Technology Co ltd
Priority to CN202010125073.9A priority Critical patent/CN111265392B/en
Publication of CN111265392A publication Critical patent/CN111265392A/en
Application granted granted Critical
Publication of CN111265392B publication Critical patent/CN111265392B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H5/00Exercisers for the eyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Rehabilitation Tools (AREA)

Abstract

本发明揭示了一种弱视治疗系统,包括:治疗仪,用于治疗弱视患者;第一应用模块,用于支付治疗费用、给治疗仪工作授权和查看弱视患者的治疗情况;第二应用模块,用于向治疗仪或者第一应用模块发送诊断处方、调节治疗仪的工作状态,以及查看弱视患者的治疗情况;服务器,用于弱视治疗系统内部各功能模块的信息交流;互动模块,用于弱视患者进行互动式治疗;治疗仪包括眼球位置识别模块,用于判断弱视患者在治疗过程中是否正确佩戴治疗仪。与现有技术相比,医生在掌握弱视患者具体病情后,即可使得弱视患者在家进行治疗。减轻弱视患者的家长的时间成本和经济成本,使得弱视患者可随时随地得到高效的治疗。

Figure 202010125073

The invention discloses an amblyopia treatment system, comprising: a treatment instrument for treating amblyopia patients; a first application module for paying treatment fees, authorizing the treatment instrument to work and checking the treatment conditions of amblyopia patients; and a second application module, It is used to send diagnostic prescriptions to the therapeutic apparatus or the first application module, adjust the working status of the therapeutic apparatus, and check the treatment status of amblyopia patients; the server is used for information exchange among functional modules in the amblyopia treatment system; the interactive module is used for amblyopia treatment system. The patient performs interactive therapy; the therapy device includes an eyeball position recognition module, which is used to judge whether the amblyopia patient wears the therapy device correctly during the treatment process. Compared with the prior art, the doctor can make the amblyopia patient treat at home after mastering the specific condition of the amblyopia patient. Reduce the time cost and economic cost of parents of amblyopia patients, so that amblyopia patients can receive efficient treatment anytime, anywhere.

Figure 202010125073

Description

一种弱视治疗系统Amblyopia treatment system

技术领域technical field

本发明涉及到眼睛治疗领域,特别是涉及到一种弱视治疗系统。The invention relates to the field of eye treatment, in particular to an amblyopia treatment system.

背景技术Background technique

在儿童发育的过程中,部分儿童会受到弱视的困扰。由于视力关乎儿童的一生,因此家长和政府都十分重视儿童的弱视治疗的问题。根据研究和临床表现证明,弱视治疗效果与年龄有强关联,年龄越小,治疗的效果越好。弱视的最佳治疗时期是儿童和青少年时期。但现在治疗方式还十分传统。弱视的实时诊断、治疗疗程管控和治疗效果反馈等环节都需要病人在医院现场。对于需要上班的父母而言,非常不便。因此,如何提升弱视病人治疗的便利性,显得十分重要。In the process of child development, some children will suffer from amblyopia. Because vision is related to children's life, parents and the government attach great importance to the treatment of children's amblyopia. According to research and clinical manifestations, the treatment effect of amblyopia has a strong correlation with age, and the younger the age, the better the treatment effect. The best time to treat amblyopia is in childhood and adolescence. But treatment is still very traditional. Real-time diagnosis of amblyopia, treatment course control and treatment effect feedback all require patients to be present in the hospital. Very inconvenient for parents who need to go to work. Therefore, how to improve the convenience of treatment for amblyopia patients is very important.

发明内容SUMMARY OF THE INVENTION

本发明的主要目的为提供一种弱视治疗系统,旨在解决弱视患者治疗的便利性的技术问题。The main purpose of the present invention is to provide an amblyopia treatment system, aiming at solving the technical problem of the convenience of treatment for amblyopia patients.

本发明提出一种弱视治疗系统,包括:The present invention provides an amblyopia treatment system, comprising:

治疗仪,用于治疗弱视患者;Therapeutic apparatus for treating amblyopia patients;

第一应用模块,用于支付治疗费用、给治疗仪工作授权和查看弱视患者的治疗情况;The first application module is used to pay the treatment fee, authorize the work of the treatment device and check the treatment status of amblyopia patients;

第二应用模块,用于向治疗仪或者第一应用模块发送诊断处方、调节治疗仪的工作状态,以及查看弱视患者的治疗情况;The second application module is used to send a diagnosis prescription to the therapeutic apparatus or the first application module, adjust the working state of the therapeutic apparatus, and check the treatment status of amblyopia patients;

服务器,用于弱视治疗系统内部各功能模块的信息交流;The server is used for information exchange of each functional module within the amblyopia treatment system;

互动模块,用于弱视患者进行互动式治疗;Interactive module for interactive treatment of amblyopia patients;

其中,in,

治疗仪包括眼球位置识别模块,用于判断弱视患者在治疗过程中是否正确佩戴治疗仪。The therapeutic apparatus includes an eyeball position recognition module, which is used to judge whether the amblyopia patient wears the therapeutic apparatus correctly during the treatment process.

优选的,治疗仪包括红光闪烁模块;Preferably, the therapeutic apparatus includes a red light flickering module;

其中,红光闪烁模块用于接收由第一应用模块或第二应用模块传输的第一诊断处方,并根据第一诊断处方产生第一图像信号和第一音频信号。Wherein, the red light flickering module is used for receiving the first diagnosis prescription transmitted by the first application module or the second application module, and generating the first image signal and the first audio signal according to the first diagnosis prescription.

优选的,治疗仪还包括后像增视模块;Preferably, the therapeutic apparatus further includes an afterimage enhancement module;

其中,后像增视模块用于接收由第一应用模块或第二应用模块传输的第二诊断处方,并根据第二诊断处方产生第二图像信号和第二音频信号。Wherein, the afterimage enhancement module is used for receiving the second diagnosis prescription transmitted by the first application module or the second application module, and generating the second image signal and the second audio signal according to the second diagnosis prescription.

优选的,治疗仪还包括CAM光栅模块;Preferably, the therapeutic apparatus further includes a CAM grating module;

其中,CAM光栅模块用于接收由第一应用模块或第二应用模块传输的第三诊断处方,并根据第三诊断处方产生第三图像信号和第三音频信号。The CAM grating module is used for receiving the third diagnostic prescription transmitted by the first application module or the second application module, and generating a third image signal and a third audio signal according to the third diagnostic prescription.

优选的,治疗仪还包括精细训练模块;Preferably, the therapeutic apparatus further includes a fine training module;

其中,精细训练模块用于接收由第一应用模块或第二应用模块传输的第四诊断处方,并根据第四诊断处方产生第四图像信号和第四音频信号。The fine training module is configured to receive the fourth diagnostic prescription transmitted by the first application module or the second application module, and generate a fourth image signal and a fourth audio signal according to the fourth diagnostic prescription.

优选的,治疗仪还包括双眼视觉训练模块;Preferably, the therapeutic apparatus further includes a binocular vision training module;

其中,双眼视觉训练模块用于接收由第一应用模块或第二应用模块传输的第五诊断处方,并根据第五诊断处方产生第五图像信号、第五音频信号和屏幕移动信号。Wherein, the binocular vision training module is used for receiving the fifth diagnosis prescription transmitted by the first application module or the second application module, and generating the fifth image signal, the fifth audio signal and the screen movement signal according to the fifth diagnosis prescription.

优选的,眼球位置识别模块包括第一识别子模块,用于提示弱视患者正确佩戴治疗仪。Preferably, the eye position identification module includes a first identification sub-module for prompting amblyopia patients to wear the therapeutic apparatus correctly.

优选的,眼球位置识别模块还包括第二识别子模块,用于提示弱视患者正确佩戴治疗仪。Preferably, the eye position identification module further includes a second identification sub-module for prompting the amblyopia patient to wear the therapeutic apparatus correctly.

优选的,治疗仪还包括身份识别模块,用于在治疗仪中绑定弱视患者的身份信息。Preferably, the therapeutic apparatus further includes an identity recognition module for binding the identity information of the amblyopia patient in the therapeutic apparatus.

优选的,治疗仪还包括预约模块,用于弱视患者输入治疗时间,并在治疗时间到达后,提醒弱视患者进行治疗。Preferably, the therapeutic apparatus further includes a reservation module for the amblyopia patient to input the treatment time, and after the treatment time arrives, remind the amblyopia patient to perform the treatment.

本发明的有益效果在于:通过本方案,医生在掌握弱视患者具体病情后,即可使得弱视患者在家进行治疗。摆脱传统弱视患者必须在医院才能得到高效治疗而造成的不方便,减轻弱视患者的家长的时间成本和经济成本,使得弱视患者可随时随地得到高效的治疗。The beneficial effect of the present invention is that: through the solution, after the doctor has grasped the specific condition of the amblyopic patient, the amblyopic patient can be treated at home. It can get rid of the inconvenience caused by traditional amblyopia patients who must be in the hospital to receive efficient treatment, reduce the time cost and economic cost of parents of amblyopia patients, and enable amblyopia patients to receive efficient treatment anytime, anywhere.

附图说明Description of drawings

图1为本发明一种弱视治疗系统的第一结构示意图;Fig. 1 is the first structural representation of a kind of amblyopia treatment system of the present invention;

图2为图1中的一种弱视治疗系统的治疗仪的第一结构示意图;Fig. 2 is the first structural representation of the therapeutic apparatus of a kind of amblyopia treatment system in Fig. 1;

图3为图1中的一种弱视治疗系统的治疗仪的第二结构示意图。FIG. 3 is a schematic diagram of a second structure of a therapeutic apparatus of an amblyopia therapeutic system in FIG. 1 .

标号说明:Label description:

1、治疗仪;1. Therapeutic instrument;

11、眼球位置识别模块;12、红光闪烁模块;13、后像增视模块;14、CAM光栅模块;15、精细训练模块;16、双眼视觉训练模块;11. Eyeball position recognition module; 12. Red light flickering module; 13. Post-image enhancement module; 14. CAM grating module; 15. Fine training module; 16. Binocular vision training module;

1A、外壳;1B、左视窗;1C、右视窗;1D、左屏幕;1E、右屏幕;1F、左屏纵向驱动马达;1G、左屏横向驱动马达;1H、右屏纵向驱动马达;1L、右屏横向驱动马达;1A, housing; 1B, left window; 1C, right window; 1D, left screen; 1E, right screen; 1F, left screen vertical drive motor; 1G, left screen horizontal drive motor; 1H, right screen vertical drive motor; 1L, Right screen lateral drive motor;

2、第一应用模块;2. The first application module;

3、第二应用模块;3. The second application module;

4、服务器;4. Server;

5、互动模块。5. Interactive module.

本发明目的的实现、功能特点及优点将结合实施例,参照附图做进一步说明。The realization, functional characteristics and advantages of the present invention will be further described with reference to the accompanying drawings in conjunction with the embodiments.

具体实施方式Detailed ways

应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention.

参照图1,本发明提供一种弱视治疗系统,包括:1, the present invention provides an amblyopia treatment system, including:

治疗仪1,用于治疗弱视患者;Therapeutic apparatus 1, used to treat amblyopia patients;

第一应用模块2,用于支付治疗费用、给治疗仪1工作授权和查看弱视患者的治疗情况;The first application module 2 is used to pay the treatment fee, authorize the treatment device 1 to work, and check the treatment status of amblyopia patients;

第二应用模块3,用于向治疗仪1或者第一应用模块2发送诊断处方、调节治疗仪1的工作状态,以及查看弱视患者的治疗情况;The second application module 3 is used to send a diagnosis prescription to the therapeutic apparatus 1 or the first application module 2, adjust the working state of the therapeutic apparatus 1, and check the treatment condition of the amblyopia patient;

服务器4,用于弱视治疗系统内部各功能模块的信息交流;The server 4 is used for information exchange of each functional module within the amblyopia treatment system;

互动模块5,用于弱视患者进行互动式治疗;Interactive module 5, used for interactive treatment of amblyopia patients;

其中,in,

治疗仪1包括眼球位置识别模块11,用于判断弱视患者在治疗过程中是否正确佩戴治疗仪1。The therapeutic apparatus 1 includes an eyeball position recognition module 11 for judging whether the amblyopia patient wears the therapeutic apparatus 1 correctly during the treatment process.

在本发明实施例中,弱视治疗系统包括治疗仪1、第一应用模块2、第二应用模块3、服务器4和互动模块5。其中,第一应用模块2为家长APP,其载体为电子设备如PC、智能手机和平板电脑等。第二应用模块3为医生APP,其载体与第一应用模块2相同。各功能模块间通信的方式包括但不限于2G/3G/4G/5G/WiFi/蓝牙/RJ45中的一种或者多种。互动模块5包括电脑鼠标或游戏手柄,与治疗仪1通信连接,用于弱视患者进行互动式治疗。本套弱视治疗系统的操作流程如下:第一步,医生在得知弱视患者的病情后,根据弱视患者的病情选择适合其的治疗内容(即生成诊断处方),并将诊断处方通过服务器4推送至第一应用模块2(即家长APP)。第二步,家长APP获取诊断处方后生成付费信息,弱视患者的家长通过家长APP进行付费。第三步,家长通过家长APP对当前治疗仪1进行工作授权,具体方式为家长APP绑定当前治疗仪1,从而家长能通过家长APP控制当前治疗仪1的工作。第四步,诊断处方通过家长APP或医生APP发送至治疗仪1,治疗仪1根据诊断处方生成治疗内容;弱视患者根据治疗内容的提示,通过鼠标或者游戏手柄与治疗内容进行交互治疗,弱视患者操作的不同结果通过治疗仪1上的喇叭发出声音提醒患者。在本发明其他实施例中,在弱视患者治疗时,眼球位置识别模块11会判断弱视患者在治疗过程中是否正确佩戴治疗仪1,避免弱视患者治疗时治疗仪1滑脱,以保证治疗效果。第五步,家长可通过家长APP,医生可通过医生APP了解弱视患者的治疗状况、完成度,以及治疗效果。通过上述设置,医生在掌握弱视患者具体病情后,即可使得弱视患者在家进行治疗。摆脱传统弱视患者必须在医院才能得到高效治疗而造成的不方便,减轻弱视患者的家长的时间成本和经济成本,使得弱视患者可随时随地得到高效的治疗。In the embodiment of the present invention, the amblyopia treatment system includes a therapeutic apparatus 1 , a first application module 2 , a second application module 3 , a server 4 and an interaction module 5 . Among them, the first application module 2 is a parent APP, and its carrier is an electronic device such as a PC, a smart phone, and a tablet computer. The second application module 3 is a doctor APP whose carrier is the same as that of the first application module 2 . The communication methods between the functional modules include but are not limited to one or more of 2G/3G/4G/5G/WiFi/Bluetooth/RJ45. The interactive module 5 includes a computer mouse or a game handle, and is connected in communication with the therapeutic apparatus 1, and is used for interactive therapy for amblyopia patients. The operation process of this amblyopia treatment system is as follows: the first step, after the doctor knows the condition of the amblyopia patient, selects the appropriate treatment content (ie, generates a diagnosis prescription) according to the condition of the amblyopia patient, and pushes the diagnosis prescription through the server 4 to the first application module 2 (ie, the parent APP). In the second step, the parent APP generates payment information after obtaining the diagnosis prescription, and the parents of the amblyopia patients pay through the parent APP. In the third step, the parent authorizes the current therapeutic apparatus 1 through the parent APP. The specific method is to bind the current therapeutic apparatus 1 to the parent APP, so that the parent can control the work of the current therapeutic apparatus 1 through the parent APP. In the fourth step, the diagnosis prescription is sent to the treatment device 1 through the parent APP or the doctor APP, and the treatment device 1 generates the treatment content according to the diagnosis prescription; the amblyopic patient interacts with the treatment content through the mouse or gamepad according to the prompt of the treatment content. Different results of the operation will alert the patient through the horn on the therapeutic apparatus 1. In other embodiments of the present invention, during the treatment of amblyopia patients, the eye position identification module 11 will determine whether the amblyopia patient wears the therapeutic apparatus 1 correctly during the treatment process, so as to avoid slippage of the therapeutic apparatus 1 during the treatment of amblyopia patients, so as to ensure the therapeutic effect. The fifth step, parents can use the parent APP, and doctors can use the doctor APP to understand the treatment status, completion degree, and treatment effect of amblyopia patients. Through the above settings, the doctor can make the amblyopia patient treat at home after mastering the specific condition of the amblyopia patient. It can get rid of the inconvenience caused by traditional amblyopia patients who must be in the hospital to receive efficient treatment, reduce the time cost and economic cost of parents of amblyopia patients, and enable amblyopia patients to receive efficient treatment anytime, anywhere.

在本发明实施例中,医生根据患者的实际病情,可通过医生APP给家长APP发送新的诊断处方,从而调整患者的治疗内容。此外,诊断处方可保存于治疗仪1、第一应用模块2、第二应用模块3和服务器4中,患者家长可通过服务器4对治疗仪1远程控制,给弱视患者进行治疗。此外,第二应用模块3根据家长的支付情况,定期生成包含日期的收入统计报表,方便医生统计自己的收入和分红情况。此外,根据患者的头部情况,医生可通过医生APP,调整治疗仪1的瞳距、屏幕、亮度和声音的大小。在本发明其他实施例中,瞳距、屏幕、亮度和声音的大小可在治疗仪1,或者通过互动模块5进行调节。在本发明实施例中,治疗仪1的工作系统包括但不限于安卓、鸿蒙、IOS及Linux系统,手机为智能手机,电脑操作系统包括但不限于Windows和Linux等系统。In the embodiment of the present invention, according to the actual condition of the patient, the doctor can send a new diagnosis prescription to the parent APP through the doctor APP, so as to adjust the treatment content of the patient. In addition, the diagnosis prescription can be stored in the therapeutic apparatus 1 , the first application module 2 , the second application module 3 and the server 4 , and the patient’s parents can remotely control the therapeutic apparatus 1 through the server 4 to treat amblyopia patients. In addition, the second application module 3 periodically generates an income statistics report including dates according to the payment status of the parents, which is convenient for doctors to calculate their own income and dividends. In addition, according to the condition of the patient's head, the doctor can adjust the interpupillary distance, screen, brightness and volume of the sound of the therapeutic apparatus 1 through the doctor APP. In other embodiments of the present invention, the interpupillary distance, screen, brightness and volume of sound can be adjusted in the therapeutic apparatus 1 or through the interactive module 5 . In the embodiment of the present invention, the working system of the therapeutic apparatus 1 includes but is not limited to Android, Hongmeng, IOS and Linux systems, the mobile phone is a smart phone, and the computer operating system includes but is not limited to systems such as Windows and Linux.

为了便于理解,本说明书结合治疗内容的实施例,具体描述弱视治疗系统的工作过程。For ease of understanding, this specification specifically describes the working process of the amblyopia treatment system in conjunction with the embodiments of the treatment content.

参照图2,治疗仪1包括外壳1A、左视窗1B、右视窗1C、左屏幕1D、右屏幕1E、左屏纵向驱动马达1F、左屏横向驱动马达1G、右屏纵向驱动马达1H、右屏横向驱动马达1L。左屏幕1D和右屏幕1E会显示具体的治疗内容如图形和视频,弱视患者通过左视窗1B和右视窗1C观察左屏幕1D和右屏幕1E显示的具体内容。Referring to FIG. 2 , the therapeutic apparatus 1 includes a housing 1A, a left window 1B, a right window 1C, a left screen 1D, a right screen 1E, a left screen vertical drive motor 1F, a left screen horizontal drive motor 1G, a right screen vertical drive motor 1H, and a right screen Lateral drive motor 1L. The left screen 1D and the right screen 1E will display the specific treatment content such as graphics and videos. The amblyopic patient observes the specific content displayed on the left screen 1D and the right screen 1E through the left window 1B and the right window 1C.

参照图3,治疗仪1包括红光闪烁模块12;Referring to FIG. 3 , the therapeutic apparatus 1 includes a red light flickering module 12;

其中,红光闪烁模块12用于接收由第一应用模块2或第二应用模块3传输的第一诊断处方,并根据第一诊断处方产生第一图像信号和第一音频信号。The red light flickering module 12 is used for receiving the first diagnosis prescription transmitted by the first application module 2 or the second application module 3, and generating the first image signal and the first audio signal according to the first diagnosis prescription.

在本发明实施例中,红光闪烁模块12根据第一诊断处方产生第一图像信号和第一音频信号,使得左屏幕1D或右屏幕1E,或者左屏幕1D和右屏幕1E产生相应的治疗内容。具体治疗内容包括:一是红点在屏幕中间闪烁,黑色背景;二是红点在屏幕中间闪烁,其周围闪烁多个绿点和蓝点,黑色背景;三是红点随机闪烁在多个绿点、蓝点位呈现,黑色背景。各颜色点的闪烁频率包括慢速、中速和快速,对应的频率分别是3.3Hz、5.0Hz和10.0Hz。红光闪烁模块12的工作时间为7分钟。治疗结束后,治疗仪1响起提示音,弱视患者听到后可摘下治疗仪1。在本发明实施例中,治疗仪1采用640纳米波长的红光闪烁刺激弱视眼,所述红光闪烁的频率为1~3.5次/秒。这疗法是根据视网膜的解剖生理设计的。黄斑中心凹仅含锥细胞,由中心向周边移行时,锥细胞急剧减少,杆细胞增多。杆细胞对光谱的红色极端不敏感,而锥细胞则敏感。促使旁中心注视眼自发地改用黄斑中心注视。红光闪烁采用红光疗法,影响治疗效果的主要参数是治疗光的闪烁频率,强度以及治疗时间。视觉的真正感光器是在视网膜上的视细胞,它们分布是不均匀的,人的视网膜黄斑部又一个中心凹,这是视网膜中感光最敏感的地方,视细胞分为视锥细胞和视杆细胞,视锥细胞对红光,绿光,蓝光敏感,并主要在白天活动使用,与明视觉有关;视杆细胞在微弱光下发生作用,主要在夜晚活动起作用,与暗视觉有关。视锥细胞密集的分布在视网膜中心部分,视杆细胞分布在周边部分。由于视网膜黄斑部中心凹仅含视锥细胞,密集度高,渐向视网膜周边部移行,视锥细胞的密集度逐渐减少,视杆细胞则逐渐增多;其中视锥细胞对红光很敏感,所有脉冲红光只刺激视锥细胞,使之兴奋,中心凹又占绝对优势,从而达到使弱视眼中心注视与整体视力提高的目的。In the embodiment of the present invention, the red light flickering module 12 generates the first image signal and the first audio signal according to the first diagnostic prescription, so that the left screen 1D or the right screen 1E, or the left screen 1D and the right screen 1E generate corresponding treatment content . The specific treatment contents include: first, the red dot flashes in the middle of the screen with a black background; second, the red dot flashes in the middle of the screen, with multiple green and blue dots flashing around it, with a black background; third, the red dot randomly flashes on multiple green dots Dots and blue dots are rendered with black background. The flickering frequencies of each color point include slow, medium and fast, and the corresponding frequencies are 3.3 Hz, 5.0 Hz and 10.0 Hz, respectively. The working time of the red light flickering module 12 is 7 minutes. After the treatment, the treatment device 1 will sound a prompt tone, and the amblyopic patient can take off the treatment device 1 after hearing it. In the embodiment of the present invention, the therapeutic apparatus 1 uses red light flickering with a wavelength of 640 nanometers to stimulate the amblyopic eye, and the frequency of the red light flickering is 1-3.5 times/second. This therapy is designed according to the anatomy and physiology of the retina. The fovea of the macula contains only cone cells, and when it migrates from the center to the periphery, the cone cells decrease sharply and the rod cells increase. Rod cells are extremely insensitive to the red extreme of the spectrum, while cone cells are. Promoting the paracentric gaze to spontaneously switch to the center of the macula. Red light flickering adopts red light therapy. The main parameters affecting the treatment effect are the flickering frequency, intensity and treatment time of the treatment light. The real photoreceptors of vision are the visual cells on the retina, and their distribution is uneven. The human retina has another central fovea, which is the most sensitive place in the retina. The visual cells are divided into cones and rods. Cells, cone cells are sensitive to red light, green light, and blue light, and are mainly used during the day, and are related to photopic vision; rod cells work in weak light, mainly at night, and are related to scotopic vision. Cone cells are densely distributed in the central part of the retina, and rod cells are distributed in the peripheral part. Since the fovea of the retina contains only cone cells, the density is high, and gradually migrates to the periphery of the retina, the density of cone cells gradually decreases, and the rod cells gradually increase; among them, cone cells are very sensitive to red light, and all The pulsed red light only stimulates the cone cells to make them excited, and the fovea has an absolute advantage, so as to achieve the purpose of improving the central gaze and overall vision of the amblyopic eye.

参照图3,治疗仪1还包括后像增视模块13;Referring to FIG. 3, the therapeutic apparatus 1 further includes an after-image enhancement module 13;

其中,后像增视模块13用于接收由第一应用模块2或第二应用模块3传输的第二诊断处方,并根据第二诊断处方产生第二图像信号和第二音频信号。The afterimage enhancement module 13 is configured to receive the second diagnostic prescription transmitted by the first application module 2 or the second application module 3, and generate a second image signal and a second audio signal according to the second diagnostic prescription.

在本发明实施例中,后像增视模块13根据第二诊断处方产生第二图像信号和第二音频信号,使得左屏幕1D或右屏幕1E,或者左屏幕1D和右屏幕1E产生相应的治疗内容。具体治疗内容包括:一是在屏幕上显示全白光加五度黑圆盘;二是在屏幕上显示全黑光加五度白圆盘。各显示图像的帧率包括慢速、中速和快速,对应的频率分别是3.3Hz、5.0Hz和10.0Hz。后像增视模块13的工作时间为7分钟。治疗结束后,治疗仪1响起提示音,弱视患者听到后可摘下治疗仪1。在本发明实施例中,治疗仪1采用白光长亮刺激弱视眼25~35秒后再转为闪烁刺激,所述闪烁刺激的频率为55~65次/分钟。当颜色刺激停止此时与此颜色有关的视束的对应过程开始活动,因而产生原种颜色的补色。眼睛接受强光照射一定时间,比如用灯管照射10秒钟,灯管熄灭之后,人眼能够看见与灯管相同的物项,即使闭上眼睛,也能够看见,这是一种生理显现,称这种物像为后像。暗适应指的是,人由明至暗最初的一瞬间一无所见以后由于视杆细胞内视紫红质的在合成,视网膜对弱光的敏感性逐渐加强才能看见东西。后像疗法用一种强光照射弱视眼眼底,同时保护黄斑中心凹免受照射。然后,再经过特殊的训练,提高中心凹的视力,这种方法称为后续疗法。In the embodiment of the present invention, the afterimage enhancement module 13 generates the second image signal and the second audio signal according to the second diagnosis prescription, so that the left screen 1D or the right screen 1E, or the left screen 1D and the right screen 1E generate corresponding treatment content. The specific treatment contents include: first, displaying a full white light plus a fifth-degree black disc on the screen; second, displaying an all-black light plus a fifth-degree white disc on the screen. The frame rates of each displayed image include slow, medium and fast, and the corresponding frequencies are 3.3 Hz, 5.0 Hz and 10.0 Hz respectively. The working time of the afterimage enhancement module 13 is 7 minutes. After the treatment, the treatment device 1 will sound a prompt tone, and the amblyopic patient can take off the treatment device 1 after hearing it. In the embodiment of the present invention, the therapeutic apparatus 1 uses white light to continuously stimulate the amblyopic eye for 25-35 seconds, and then switches to flicker stimulation, and the frequency of the flicker stimulation is 55-65 times/min. When the color stimulus stops, the corresponding process of the optic tract related to this color starts to work, thus producing the complementary color of the original color. The eyes are exposed to strong light for a certain period of time, such as irradiating with a light tube for 10 seconds. After the light tube is turned off, the human eye can see the same items as the light tube. Even if you close your eyes, you can see it. This is a physiological manifestation. Call this image an afterimage. Dark adaptation refers to the fact that the retina becomes increasingly sensitive to weak light due to the synthesis of rhodopsin in the rod cells after the initial moment of blindness from light to dark. Afterimage therapy illuminates the fundus of the amblyopic eye with a strong light while protecting the fovea from exposure. Then, after special training to improve foveal vision, this method is called follow-up therapy.

参照图3,治疗仪1还包括CAM光栅模块14;3, the therapeutic apparatus 1 further includes a CAM grating module 14;

其中,CAM光栅模块14用于接收由第一应用模块2或第二应用模块3传输的第三诊断处方,并根据第三诊断处方产生第三图像信号和第三音频信号。The CAM grating module 14 is configured to receive the third diagnostic prescription transmitted by the first application module 2 or the second application module 3, and generate a third image signal and a third audio signal according to the third diagnostic prescription.

在本发明实施例中,CAM光栅模块14根据第三诊断处方产生第三图像信号和第三音频信号,使得左屏幕1D或右屏幕1E,或者左屏幕1D和右屏幕1E产生相应的治疗内容。具体治疗内容包括:根据弱视患者视力高低,将治疗图像分成十种不同等级的空间频率,分别是0.1CAM、0.2CAM、0.3CAM、0.4CAM、0.5CAM、0.6CAM、0.7CAM、0.8CAM、0.9CAM和1.0CAM。每种空间频率的治疗图像均包括地图、马和乌龟,三种待患者描绘的图像。具体操作流程为患者根据视力高低,运用不同空间频率的治疗图像,按照先后顺序,通过互动模块5依次描绘地图、马和乌龟,三种图像的描绘时间均是7分钟。弱视患者通过治疗仪1的上下左右按键,将光标移动至马外形相应位置,点击OK按键一个点描红成功,同时发出正确提示音,直到马描绘完成发出结束提示音。地图和乌龟的描绘过程与马相同,故不再赘述。在本发明实施例中,治疗仪1采用转动的光栅刺激弱视眼,所述光栅的转动频率为1~1.5周/分钟。光栅刺激疗法也称视刺激疗法,该法容易使视觉神经轴突得到活化。光栅的条栅可转,利用反差强,空间频率不同的条栅作为刺激源刺激弱视眼,使弱视眼的视细胞在各个方位上都能接受不同方向的条栅刺激;使中枢细胞增强发育并提高视力。因为不同程度的弱视眼分辨力是不同的,因此视力从低到高应选择不同空间频率的图像进行刺激,才能生产最好的效果,才对弱视治疗有意义。人的大脑各种颜色的图案或不同宽度的光栅都有不同的反应,可以根据患者的视力高低来选择各种的光栅来刺激弱视患者,来提高他们的视力。In the embodiment of the present invention, the CAM grating module 14 generates the third image signal and the third audio signal according to the third diagnostic prescription, so that the left screen 1D or the right screen 1E, or the left screen 1D and the right screen 1E generate corresponding treatment content. The specific treatment contents include: according to the visual acuity of amblyopia patients, the treatment images are divided into ten different levels of spatial frequencies, namely 0.1CAM, 0.2CAM, 0.3CAM, 0.4CAM, 0.5CAM, 0.6CAM, 0.7CAM, 0.8CAM, 0.9 CAM and 1.0CAM. The treatment images for each spatial frequency included maps, horses and turtles, three images to be depicted by the patient. The specific operation process is that the patient uses the treatment images of different spatial frequencies according to the level of vision, and sequentially depicts the map, the horse and the turtle through the interactive module 5, and the depiction time of the three images is 7 minutes. The amblyopic patient moves the cursor to the corresponding position of the horse shape through the up, down, left, and right buttons of the therapeutic apparatus 1, clicks the OK button to successfully draw a red dot, and at the same time emits a correct prompt sound, until the horse drawing is completed and the end prompt sound is issued. The process of drawing maps and turtles is the same as that of horses, so I won't repeat them. In the embodiment of the present invention, the therapeutic apparatus 1 uses a rotating grating to stimulate the amblyopic eye, and the rotating frequency of the grating is 1-1.5 cycles/min. Grating stimulation therapy, also known as visual stimulation therapy, is easy to activate the optic nerve axons. The gratings of the grating can be rotated, and the gratings with strong contrast and different spatial frequencies are used as stimulation sources to stimulate the amblyopic eye, so that the visual cells of the amblyopic eye can receive the grating stimulation in different directions in all directions; the central cells can be enhanced and developed. Improve eyesight. Because different degrees of amblyopic eyes have different resolutions, images with different spatial frequencies should be selected for stimulation from low to high visual acuity, in order to produce the best effect, which is meaningful for the treatment of amblyopia. Various color patterns or gratings of different widths in the human brain have different responses. Various gratings can be selected according to the patient's visual acuity to stimulate amblyopic patients to improve their vision.

参照图3,治疗仪1还包括精细训练模块15;3, the therapeutic apparatus 1 further includes a fine training module 15;

其中,精细训练模块15用于接收由第一应用模块2或第二应用模块3传输的第四诊断处方,并根据第四诊断处方产生第四图像信号和第四音频信号。The fine training module 15 is configured to receive the fourth diagnostic prescription transmitted by the first application module 2 or the second application module 3, and generate a fourth image signal and a fourth audio signal according to the fourth diagnostic prescription.

在本发明实施例中,精细训练模块15根据第四诊断处方产生第四图像信号和第四音频信号,使得左屏幕1D或右屏幕1E,或者左屏幕1D和右屏幕1E产生相应的治疗内容。具体治疗内容包括:屏幕上具有20个显示数字的小方格以及1个显示提示数字的大方格。患者需根据大方格中显示的数字,通过互动模块5,在小方格中选中该提示数字。若患者选中,则语音提示选择成功,进入下一轮训练;若患者选择失败,则语音提示选择失败。在本发明其他实施例中,在患者进入下一轮训练之前,大方格中提示数字的数值会更改,原有20个显示数字的排序会随机打乱。在本发明其他实施例中,屏幕上显示的图像可从数字更改为字母,其余环节均不改变。精细作业是其中的一种辅助方法用以刺激弱视眼,作业机制类似刺激疗法,项目种类包括图案辨别、描画等。在训练的时候,可遮盖健康眼,从而单独训练弱视眼。通过这些精细的操作,促进视觉系统的发育,达到治疗弱视的目的。精细训练对于弱视眼是一种良好的应用,也是一种特别针对性的锻炼,有利于视觉发育和提高视力。通过这些精细的操作,促进视觉系统的发育,达到治疗弱视的目的。In the embodiment of the present invention, the fine training module 15 generates the fourth image signal and the fourth audio signal according to the fourth diagnosis prescription, so that the left screen 1D or the right screen 1E, or the left screen 1D and the right screen 1E generate corresponding treatment content. The specific treatment contents include: 20 small squares displaying numbers and 1 large square displaying prompt numbers on the screen. The patient needs to select the prompt number in the small square through the interactive module 5 according to the number displayed in the large square. If the patient is selected, the voice prompts that the selection is successful and enters the next round of training; if the patient's selection fails, the voice prompts that the selection fails. In other embodiments of the present invention, before the patient enters the next round of training, the numerical value of the prompt numbers in the large square will be changed, and the order of the original 20 displayed numbers will be randomly shuffled. In other embodiments of the present invention, the images displayed on the screen can be changed from numbers to letters, and the rest of the links remain unchanged. Fine work is one of the auxiliary methods to stimulate the amblyopic eye. The work mechanism is similar to stimulation therapy. The types of projects include pattern recognition and drawing. During training, the healthy eye can be covered to train the amblyopic eye alone. Through these fine operations, the development of the visual system is promoted, and the purpose of treating amblyopia is achieved. Fine training is a good application for amblyopic eyes, and it is also a special targeted exercise, which is conducive to visual development and improvement of vision. Through these fine operations, the development of the visual system is promoted, and the purpose of treating amblyopia is achieved.

参照图3,治疗仪1还包括双眼视觉训练模块16;3, the therapeutic apparatus 1 also includes a binocular vision training module 16;

其中,双眼视觉训练模块16用于接收由第一应用模块2或第二应用模块3传输的第五诊断处方,并根据第五诊断处方产生第五图像信号、第五音频信号和屏幕移动信号。The binocular vision training module 16 is configured to receive the fifth diagnostic prescription transmitted by the first application module 2 or the second application module 3, and generate a fifth image signal, a fifth audio signal and a screen movement signal according to the fifth diagnostic prescription.

在本发明实施例中,双眼视觉训练模块16根据第五诊断处方产生第五图像信号和第五音频信号,使得左屏幕1D和右屏幕1E产生相应的治疗内容,左屏纵向驱动马达1F、左屏横向驱动马达1G、右屏纵向驱动马达1H和右屏横向驱动马达1L根据屏幕移动信号分别驱动左屏纵向驱动马达1F、左屏横向驱动马达1G、右屏纵向驱动马达1H、右屏横向驱动马达1L的运动。具体治疗内容包括同时视训练和融像训练。In the embodiment of the present invention, the binocular vision training module 16 generates the fifth image signal and the fifth audio signal according to the fifth diagnosis prescription, so that the left screen 1D and the right screen 1E generate corresponding treatment contents, and the left screen drives the motor 1F, left The screen horizontal drive motor 1G, the right screen vertical drive motor 1H and the right screen horizontal drive motor 1L respectively drive the left screen vertical drive motor 1F, the left screen horizontal drive motor 1G, the right screen vertical drive motor 1H and the right screen horizontal drive according to the screen movement signal. Movement of the motor 1L. The specific treatment content includes simultaneous visual training and fusion training.

在本发明实施例中,左屏幕1D和右屏幕1E分别显示一图像,比如图像为蝴蝶在花边飞舞,其中,两个图像中花的形状、大小和位置相同,两个图像中的蝴蝶以花茎为对称轴对对称设置。弱视患者通过互动模块5如游戏手柄,控制左屏幕1D和右屏幕1E产生相对运动的速度,在两幅图像中的花重合时,通过按压游戏手柄上的按键,重合两幅图像。若重合成功,则语音提示成功;若重合失败,则语音提示失败,左屏幕1D和右屏幕1E会朝相反方向运动,使得弱视患者重新开始训练。在本发明其他实施例中,若两幅图像重合成功后,弱视患者通过按压游戏手柄上的按键,使左屏幕1D和右屏幕1E朝相反方向运动,可以使患者进行下一图像的训练。在本发明实施例中,同时视是指两眼具有同时接受物像的能力,但物像不必完全重合,这是形成双眼视觉的基础调节,也称一级视功能。例如:一朵花与一只蝴蝶,把这样的一对画面分别放入治疗仪器屏幕左右画面内检查患者,被检者左眼看花,右眼看蝴蝶,如果双眼能同时看见花和蝴蝶,并在按键点击图片移动使得蝴蝶进入花。说明是皮层中枢能同时接受分别落在两眼黄斑部的刺激,亦即被检者没有黄斑抑制,存在同时视。如若虽双眼能同时看见花和蝴蝶,但不能将它们重叠起来,则说明被检者黄斑部有某种抑制,同时视不良。In the embodiment of the present invention, the left screen 1D and the right screen 1E respectively display an image, for example, the image is a butterfly flying on the lace, wherein the shape, size and position of the flower in the two images are the same, and the butterfly in the two images is represented by a flower stem Set for symmetry axis pair symmetry. The amblyopic patient controls the relative movement speed of the left screen 1D and the right screen 1E through the interactive module 5 such as a gamepad. When the flowers in the two images overlap, the two images are overlapped by pressing the buttons on the gamepad. If the coincidence is successful, the voice prompt is successful; if the coincidence fails, the voice prompt fails, and the left screen 1D and the right screen 1E will move in opposite directions, so that the amblyopic patient starts training again. In other embodiments of the present invention, if the two images are overlapped successfully, the patient with amblyopia can move the left screen 1D and the right screen 1E in opposite directions by pressing the buttons on the game handle, so that the patient can train the next image. In the embodiment of the present invention, simultaneous vision means that both eyes have the ability to simultaneously receive object images, but the object images do not have to be completely coincident, which is the basic adjustment for forming binocular vision, also called primary vision function. For example: a flower and a butterfly, put such a pair of pictures into the left and right pictures of the treatment equipment screen to examine the patient. The examinee looks at the flower with the left eye and the butterfly with the right eye. Click the button to move the picture so that the butterfly enters the flower. It means that the cortical center can simultaneously receive the stimuli that fall on the macula of both eyes, that is to say, the subject has no macular inhibition and has simultaneous vision. If both eyes can see flowers and butterflies at the same time, but they cannot be overlapped, it means that the subject has some kind of inhibition in the macula, and visual impairment at the same time.

在本发明实施例中,左屏幕1D和右屏幕1E分别显示一图像,比如左屏幕1D显示的图像为笼子,笼子的中心具有红点;右屏幕1E显示的图像为老虎,老虎的中心也具有红点。弱视患者通过互动模块5如游戏手柄,控制左屏幕1D和右屏幕1E产生相对运动的速度,当笼子的红点与老虎的红点重合时,弱视患者需按压游戏手柄上的按键,完成笼子与老虎的融合,即准确将老虎整体装入笼子。若融合成功,则治疗仪1语音提示“融合成功”;若融合失败,则语音提示“融合失败”,左屏幕1D和右屏幕1E会朝相反方向运动,使得弱视患者重新开始训练。在本发明其他实施例中,若两幅图像重合成功后,弱视患者通过按压游戏手柄上的按键,使左屏幕1D和右屏幕1E朝相反方向运动,可以使患者进行下一图像的训练。在本发明实施例中,融像是指大脑能综合来自双眼的相似物,并在知觉水平上形成一个完整印象的能力。亦指在具有双眼同时视的基础上,把落在两眼视网膜对应点上的物像综合为一个完整印象的能力,也称二级视功能。除上述情况外,还包括当两眼物像偏离黄斑部时,仍有足够的能力维持一个完整物像。在能引起融合反射的情况下,视网膜物像的位移幅度称为融合范围,常作为衡量双眼视觉功能正常与否的标志。例如:一张画面为笼子,另一张为老虎。两眼具有这些融合功能的被检者,当两眼同时看画面时,能看见一副完整的老虎在笼子中的画面。在左眼眼镜筒在一对角度范围内,同时集合或分开,仍能维持融合。正常人的融合范围为:水平方向集合范围为4°~6°,散开范围约4°~6°,垂直方向融合范围约2°~3°。In the embodiment of the present invention, an image is displayed on the left screen 1D and the right screen 1E respectively. For example, the image displayed on the left screen 1D is a cage, and the center of the cage has a red dot; the image displayed on the right screen 1E is a tiger, and the center of the tiger also has a red dot. Red dot. The amblyopic patient controls the relative movement speed of the left screen 1D and the right screen 1E through the interactive module 5, such as a gamepad. When the red dot of the cage coincides with the red dot of the tiger, the amblyopic patient needs to press the button on the gamepad to complete the connection between the cage and the tiger. The fusion of tigers, that is, the accurate loading of the tiger as a whole into the cage. If the fusion is successful, the therapeutic apparatus 1 will give a voice prompt of "fusion success"; if the fusion fails, the voice prompt "fusion failure", the left screen 1D and the right screen 1E will move in opposite directions, so that the amblyopic patient restarts training. In other embodiments of the present invention, if the two images are overlapped successfully, the patient with amblyopia can move the left screen 1D and the right screen 1E in opposite directions by pressing the buttons on the game handle, so that the patient can train the next image. In embodiments of the present invention, fusion refers to the ability of the brain to synthesize similarities from both eyes and form a complete impression at the perceptual level. It also refers to the ability to synthesize the images falling on the corresponding points of the retinas of both eyes into a complete impression on the basis of simultaneous vision of both eyes, also known as secondary visual function. In addition to the above cases, it also includes that when the object image of both eyes deviates from the macula, there is still enough ability to maintain a complete object image. In the case of causing fusion reflection, the displacement range of the retinal object image is called fusion range, which is often used as a sign to measure whether the visual function of both eyes is normal or not. For example: one picture is a cage, the other is a tiger. Subjects with these fusion functions in both eyes can see a complete picture of a tiger in a cage when both eyes look at the picture at the same time. Convergence can still be maintained when the left eye spectacle barrels are within a pair of angles, while being assembled or separated. The fusion range of normal people is: the horizontal collection range is 4° to 6°, the spread range is about 4° to 6°, and the vertical fusion range is about 2° to 3°.

在本发明其他实施例中,治疗内容还包括立体视训练。左屏幕1D和右屏幕1E分别显示一图像,其中,左屏幕1D显示的图像和右屏幕1E显示的图像为对称的图像。具体训练方法为弱视患者两眼同时观看,在显示的图案找出有立体感的圆圈。在本发明实施例中,立体视是建立在双眼同时视、融像基础上的一种较为独立的双眼视觉功能。当双眼观察一个物体时,该物体在双眼视网膜上形成微小的水平视差,通过视中枢综合分析后,最终形成的物像具有立体知觉。由立体视建立起来的立体感属于三维空间知觉,它是最高级的双眼单视功能,又称为三级视功能。立体视画片包括一般立体视画片及随机点立体视画片,前者用于立体视的定性测定,后者用于立体视锐度的定量测定。立体视画片的特点是两张画图案看似完全相同,但每张图片的图案相对画片中心在水平方向上存在微量的位移,从而使被检者在观看时,左右两眼视网膜上形成微小的水平视差、被视中枢感知会产生深度知觉,从而产生立体感。检查时,画面水平位移量的差别会使被检者产生不同的立体视差角。In other embodiments of the present invention, the treatment content further includes stereoscopic training. The left screen 1D and the right screen 1E respectively display an image, wherein the image displayed on the left screen 1D and the image displayed on the right screen 1E are symmetrical images. The specific training method is to watch both eyes of amblyopia patients at the same time, and find a three-dimensional circle in the displayed pattern. In the embodiment of the present invention, stereopsis is a relatively independent binocular vision function based on binocular simultaneous vision and fusion. When two eyes observe an object, the object forms a tiny horizontal parallax on the retinas of both eyes. After comprehensive analysis by the visual center, the final image of the object has three-dimensional perception. The stereoscopic sense established by stereoscopic vision belongs to three-dimensional space perception, which is the most advanced binocular monovision function, also known as tertiary vision function. Stereoscopic pictures include general stereoscopic pictures and random point stereoscopic pictures, the former is used for qualitative determination of stereoscopic vision, and the latter is used for quantitative determination of stereoscopic acuity. The characteristic of the stereoscopic picture is that the two pictures appear to be identical, but the pattern of each picture has a slight displacement in the horizontal direction relative to the center of the picture, so that when the examinee is watching, tiny tiny holes are formed on the retinas of the left and right eyes. Horizontal parallax, perceived by the visual center, will produce depth perception, resulting in three-dimensional perception. During inspection, the difference in the horizontal displacement of the screen will cause the subject to produce different stereo parallax angles.

进一步地,眼球位置识别模块11包括第一识别子模块,用于提示弱视患者正确佩戴治疗仪1。Further, the eye position identification module 11 includes a first identification sub-module for prompting the amblyopia patient to wear the therapeutic apparatus 1 correctly.

在本发明实施例中,在治疗仪1开始治疗前,左屏幕1D和右屏幕1E分别与左视窗1B和右视窗1C相对设置。左屏幕1D和右屏幕1E的顶部中心分别具有一眼球位置识别模块11,即第一识别子模块。该第一识别子模块具体为一针孔摄像头,通过针孔摄像头分别获取弱视患者左右眼球的位置。当弱视患者眼球位于左视窗1B和右视窗1C时,针孔摄像头能获取弱视患者完整的左右眼球图像,并将眼球图像发送至治疗仪1的处理器上。处理器分析图像信息,当弱视患者眼球图像信息不完整时(比如只获取到半个眼球),治疗仪1会发生警报,提醒患者正确佩戴治疗仪1,并将警报信息发送至家长APP和医生APP。通过上述设置,将针孔摄像头集成在左屏幕1D和右屏幕1E,高度集成化,使得治疗仪1追踪弱视患者眼球位置,保证治疗效果的的同时,不增加产品体积。通过将警报信息发送至家长APP和医生APP,当治疗仪1在治疗过程中滑脱次数超过预警值时,则判定当次治疗无效,需重新治疗,使得家长和医生无需实时现场监督儿童患者进行治疗,便可得知治疗情况。In the embodiment of the present invention, before the treatment apparatus 1 starts treatment, the left screen 1D and the right screen 1E are respectively disposed opposite to the left window 1B and the right window 1C. The top centers of the left screen 1D and the right screen 1E respectively have an eyeball position recognition module 11 , that is, a first recognition sub-module. The first identification sub-module is specifically a pinhole camera, and the positions of the left and right eyeballs of the amblyopia patient are obtained respectively through the pinhole camera. When the eyeballs of the amblyopic patient are located in the left window 1B and the right window 1C, the pinhole camera can acquire the complete left and right eyeball images of the amblyopic patient, and send the eyeball images to the processor of the therapeutic apparatus 1 . The processor analyzes the image information. When the image information of the eyeball of the amblyopia patient is incomplete (for example, only half of the eyeball is obtained), the therapy device 1 will generate an alarm to remind the patient to wear the therapy device 1 correctly, and send the alarm information to the parent APP and the doctor APP. Through the above setting, the pinhole camera is integrated on the left screen 1D and the right screen 1E, which is highly integrated, so that the therapeutic apparatus 1 can track the eye position of the amblyopia patient, so as to ensure the therapeutic effect without increasing the product volume. By sending the alarm information to the parent APP and the doctor APP, when the number of slippage of the therapeutic apparatus 1 exceeds the warning value during the treatment process, it is determined that the current treatment is invalid and needs to be re-treated, so that the parents and doctors do not need to supervise the child patient on the spot in real time for treatment. , the treatment status can be known.

进一步地,眼球位置识别模块11包括第二识别子模块,用于提示弱视患者正确佩戴治疗仪1。Further, the eye position identification module 11 includes a second identification sub-module for prompting the amblyopia patient to wear the therapeutic apparatus 1 correctly.

在本发明实施例中,左视窗1B和右视窗1C所在的外壳1A的侧壁为佩戴区,左视窗1B和右视窗1C为治疗区,佩戴区的其他区域为非治疗区。非治疗区上设有深度传感器,在弱视患者治疗时可获得患者脸部的深度信息。治疗仪1的处理器提前存储有弱视患者头部的三维模型,即患者脸部各部位的深度信息。弱视患者正确佩戴治疗仪1时,佩戴区的覆盖范围为患者眉毛顶部及眼袋底部之间的脸部。治疗仪1在治疗前,通过深度传感器,获取眉毛顶部及眼袋底部的深度信息,其中,该深度信息不包含眼球的深度信息。深度传感器在获取深度信息,通过比较三维模型中佩戴区覆盖的脸部范围的深度信息的误差是否小于预设范围,若是,则表示患者佩戴正确;若否,则表示患者佩戴不正确,产生警报信息,提醒患者纠正佩戴位置,并将警报信息发送至家长APP和医生APP。通过上述设置,由于人眼在脸部的相对位置不发生改变,只要识别眼部周围骨架的深度信息与预存的人脸模型的深度信息进行比较,即可判断患者眼部是否在治疗区。多元化的识别患者是否正确佩戴治疗仪1的方式,能避免单一方式失效时,治疗仪1无法识别患者是否正确佩戴治疗仪1。In the embodiment of the present invention, the side walls of the housing 1A where the left and right windows 1B and 1C are located are the wearing areas, the left and right windows 1B and 1C are treatment areas, and other areas of the wearing area are non-treatment areas. There is a depth sensor on the non-treatment area, and the depth information of the patient's face can be obtained during the treatment of amblyopia patients. The processor of the therapeutic apparatus 1 stores the three-dimensional model of the head of the amblyopia patient in advance, that is, the depth information of each part of the patient's face. When the amblyopia patient wears the therapeutic apparatus 1 correctly, the coverage of the wearing area is the face between the top of the patient's eyebrows and the bottom of the eye bag. Before treatment, the therapeutic apparatus 1 obtains the depth information of the top of the eyebrow and the bottom of the eye bag through the depth sensor, wherein the depth information does not include the depth information of the eyeball. When the depth sensor obtains depth information, it compares whether the error of the depth information of the face area covered by the wearing area in the 3D model is smaller than the preset range. If so, it means that the patient is wearing it correctly; if not, it means that the patient is wearing incorrectly, and an alarm is generated. information, remind the patient to correct the wearing position, and send the alarm information to the parent APP and the doctor APP. With the above settings, since the relative position of the human eyes on the face does not change, it can be determined whether the patient's eyes are in the treatment area as long as the depth information of the identified skeleton around the eyes is compared with the depth information of the pre-stored face model. Diversified ways of identifying whether the patient is wearing the therapeutic apparatus 1 correctly can prevent the therapeutic apparatus 1 from being unable to identify whether the patient is wearing the therapeutic apparatus 1 correctly when a single method fails.

进一步地,治疗仪1还包括预约模块,用于弱视患者输入治疗时间,并在治疗时间到达后,提醒弱视患者进行治疗。Further, the therapeutic apparatus 1 further includes a reservation module for the amblyopia patient to input the treatment time, and after the treatment time arrives, remind the amblyopia patient to perform the treatment.

在本发明实施例中,治疗仪1还包括预约模块,具体为一触控屏,触控屏位于外壳表面,远离佩戴区。弱视患者通过触控屏输入治疗时间,并将治疗时间发送至家长APP和医生APP。弱视患者在治疗仪1上输入治疗时间不仅能加深印象,到期提醒,而且通过多元化的预约方式,对于没有手机的儿童,也能自己把控治疗时间。In the embodiment of the present invention, the therapeutic apparatus 1 further includes a reservation module, which is specifically a touch screen, and the touch screen is located on the surface of the casing, away from the wearing area. Amblyopia patients input the treatment time through the touch screen, and send the treatment time to the parent APP and the doctor APP. Amblyopia patients can not only deepen their impression and remind them when they enter the treatment time on the treatment device 1, but also can control the treatment time for children without mobile phones through a variety of appointment methods.

进一步地,治疗仪1还包括身份识别模块,用于在治疗仪1中绑定弱视患者的身份信息。Further, the therapeutic apparatus 1 further includes an identity recognition module for binding the identity information of the amblyopia patient in the therapeutic apparatus 1 .

在本发明实施例中,身份识别模块为位于外壳1A表面的显示屏,显示屏显示表示用户身份的二维码,不同用户的二维码均不同。家长通过家长APP,扫码绑定治疗仪1,从而获取该治疗仪1的控制权。通过上述设置,当治疗仪1更换用户时,只需在显示屏上生成新的二维码,其他患者即可绑定使用该治疗仪1,使得治疗仪1循环利用,提高利用率。在本发明其他实施例中,身份识别模块为一二维码贴纸,粘贴于外壳1A表面。该方法简单,成本低,适于大批量生产。In the embodiment of the present invention, the identity recognition module is a display screen located on the surface of the casing 1A, and the display screen displays a two-dimensional code representing the user's identity, and the two-dimensional code of different users is different. Parents can scan the code to bind the therapeutic device 1 through the parent APP, so as to obtain the control right of the therapeutic device 1. Through the above settings, when the therapeutic apparatus 1 changes users, it is only necessary to generate a new two-dimensional code on the display screen, and other patients can bind and use the therapeutic apparatus 1, so that the therapeutic apparatus 1 can be recycled and the utilization rate is improved. In other embodiments of the present invention, the identity recognition module is a two-dimensional code sticker, which is pasted on the surface of the casing 1A. The method is simple, low in cost and suitable for mass production.

以上所述仅为本发明的优选实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书及附图内容所作的等效结构或等效流程变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the scope of the present invention. Any equivalent structure or equivalent process transformation made by using the contents of the description and drawings of the present invention, or directly or indirectly applied to other related All technical fields are similarly included in the scope of patent protection of the present invention.

Claims (9)

1.一种弱视治疗系统,其特征在于,包括:1. an amblyopia treatment system, is characterized in that, comprises: 治疗仪,用于治疗弱视患者;Therapeutic apparatus for treating amblyopia patients; 第一应用模块,用于支付治疗费用、给所述治疗仪工作授权和查看所述弱视患者的治疗情况;The first application module is used to pay the treatment fee, authorize the work of the therapeutic apparatus and check the treatment condition of the amblyopia patient; 第二应用模块,用于向所述治疗仪或者所述第一应用模块发送诊断处方、调节所述治疗仪的工作状态,以及查看所述弱视患者的治疗情况;a second application module, configured to send a diagnosis prescription to the therapeutic apparatus or the first application module, adjust the working state of the therapeutic apparatus, and check the treatment status of the amblyopia patient; 服务器,用于所述弱视治疗系统内部各功能模块的信息交流;A server, used for information exchange of each functional module inside the amblyopia treatment system; 互动模块,用于所述弱视患者进行互动式治疗;an interactive module for interactive treatment of the amblyopia patient; 其中,in, 所述治疗仪包括眼球位置识别模块,用于判断所述弱视患者在治疗过程中是否正确佩戴所述治疗仪;The therapeutic apparatus includes an eyeball position recognition module for judging whether the amblyopic patient wears the therapeutic apparatus correctly during the treatment process; 所述眼球位置识别模块包括第一识别子模块,用于提示所述弱视患者正确佩戴所述治疗仪;The eyeball position identification module includes a first identification sub-module for prompting the amblyopia patient to wear the therapeutic apparatus correctly; 所述治疗仪还包括深度传感器,所述治疗仪预存有所述弱视患者头部的三维模型,所述三维模型包括所述弱视患者脸部各部位的深度信息,所述治疗仪在治疗前通过所述深度传感器获取所述弱视患者脸部的实际深度信息,通过比较所述实际深度信息与预存的所述三维模型中的深度信息的误差是否小于预设范围,若是,则表示患者佩戴正确,若否,则表示患者佩戴不正确。The therapeutic apparatus further includes a depth sensor, and the therapeutic apparatus pre-stores a three-dimensional model of the head of the amblyopia patient, and the three-dimensional model includes the depth information of each part of the face of the amblyopia patient, and the therapeutic apparatus passes through before the treatment. The depth sensor obtains the actual depth information of the face of the amblyopic patient, and compares whether the error between the actual depth information and the depth information in the pre-stored three-dimensional model is less than a preset range, and if so, it means that the patient is wearing it correctly, If not, the patient is not wearing it correctly. 2.根据权利要求1所述的弱视治疗系统,其特征在于,所述治疗仪包括红光闪烁模块;2. The amblyopia treatment system according to claim 1, wherein the treatment instrument comprises a red light flickering module; 其中,所述红光闪烁模块用于接收由所述第一应用模块或所述第二应用模块传输的第一诊断处方,并根据所述第一诊断处方产生第一图像信号和第一音频信号。Wherein, the red light flickering module is used to receive the first diagnostic prescription transmitted by the first application module or the second application module, and generate a first image signal and a first audio signal according to the first diagnostic prescription . 3.根据权利要求1所述的弱视治疗系统,其特征在于,所述治疗仪还包括后像增视模块;3. amblyopia treatment system according to claim 1, is characterized in that, described treatment apparatus also comprises afterimage enhancement module; 其中,所述后像增视模块用于接收由所述第一应用模块或所述第二应用模块传输的第二诊断处方,并根据所述第二诊断处方产生第二图像信号和第二音频信号。Wherein, the afterimage enhancement module is configured to receive the second diagnosis prescription transmitted by the first application module or the second application module, and generate a second image signal and a second audio frequency according to the second diagnosis prescription Signal. 4.根据权利要求1所述的弱视治疗系统,其特征在于,所述治疗仪还包括CAM光栅模块;4. The amblyopia treatment system according to claim 1, wherein the treatment apparatus further comprises a CAM grating module; 其中,所述CAM光栅模块用于接收由所述第一应用模块或所述第二应用模块传输的第三诊断处方,并根据所述第三诊断处方产生第三图像信号和第三音频信号。The CAM grating module is configured to receive a third diagnostic prescription transmitted by the first application module or the second application module, and generate a third image signal and a third audio signal according to the third diagnostic prescription. 5.根据权利要求1所述的弱视治疗系统,其特征在于,所述治疗仪还包括精细训练模块;5. The amblyopia treatment system according to claim 1, wherein the treatment apparatus further comprises a fine training module; 其中,所述精细训练模块用于接收由所述第一应用模块或所述第二应用模块传输的第四诊断处方,并根据所述第四诊断处方产生第四图像信号和第四音频信号。The fine training module is configured to receive a fourth diagnostic prescription transmitted by the first application module or the second application module, and generate a fourth image signal and a fourth audio signal according to the fourth diagnostic prescription. 6.根据权利要求1所述的弱视治疗系统,其特征在于,所述治疗仪还包括双眼视觉训练模块;6. amblyopia treatment system according to claim 1, is characterized in that, described treatment apparatus also comprises binocular vision training module; 其中,所述双眼视觉训练模块用于接收由所述第一应用模块或所述第二应用模块传输的第五诊断处方,并根据所述第五诊断处方产生第五图像信号、第五音频信号和屏幕移动信号。Wherein, the binocular vision training module is configured to receive a fifth diagnostic prescription transmitted by the first application module or the second application module, and generate a fifth image signal and a fifth audio signal according to the fifth diagnostic prescription and screen mobile signal. 7.根据权利要求1所述的弱视治疗系统,其特征在于,所述眼球位置识别模块还包括第二识别子模块,用于提示所述弱视患者正确佩戴所述治疗仪。7 . The amblyopia treatment system according to claim 1 , wherein the eyeball position identification module further comprises a second identification sub-module for prompting the amblyopia patient to wear the treatment apparatus correctly. 8 . 8.根据权利要求1所述的弱视治疗系统,其特征在于,所述治疗仪还包括身份识别模块,用于在所述治疗仪中绑定所述弱视患者的身份信息。8 . The amblyopia treatment system according to claim 1 , wherein the treatment apparatus further comprises an identification module for binding the identification information of the amblyopia patient in the treatment apparatus. 9 . 9.根据权利要求1所述的弱视治疗系统,其特征在于,所述治疗仪还包括预约模块,用于所述弱视患者输入治疗时间,并在所述治疗时间到达后,提醒所述弱视患者进行治疗。9. The amblyopia treatment system according to claim 1, wherein the therapeutic apparatus further comprises a reservation module for the amblyopia patient to input a treatment time, and after the treatment time arrives, reminding the amblyopia patient Get treatment.
CN202010125073.9A 2020-02-27 2020-02-27 Amblyopia treatment system Active CN111265392B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010125073.9A CN111265392B (en) 2020-02-27 2020-02-27 Amblyopia treatment system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010125073.9A CN111265392B (en) 2020-02-27 2020-02-27 Amblyopia treatment system

Publications (2)

Publication Number Publication Date
CN111265392A CN111265392A (en) 2020-06-12
CN111265392B true CN111265392B (en) 2022-05-03

Family

ID=70994119

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010125073.9A Active CN111265392B (en) 2020-02-27 2020-02-27 Amblyopia treatment system

Country Status (1)

Country Link
CN (1) CN111265392B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113101159B (en) * 2021-04-08 2023-08-04 杭州深睿博联科技有限公司 VR-based stereoscopic vision training and evaluating method and device
CN114886741A (en) * 2022-04-18 2022-08-12 杭州宝尔科技有限公司 3D (three-dimensional) stereoscopic myopia and amblyopia fusion vision therapeutic apparatus and detection method
CN114887233B (en) * 2022-07-15 2023-04-11 北京鹰瞳科技发展股份有限公司 Red light irradiation control device for myopia physiotherapy and related product thereof
CN115444722A (en) * 2022-10-08 2022-12-09 快视(天津)科技有限公司 Eye training method
CN117809833B (en) * 2024-02-29 2024-05-31 中国人民解放军总医院第一医学中心 Remote intelligent peritoneal dialysis system
TWI879503B (en) * 2024-03-20 2025-04-01 南臺學校財團法人南臺科技大學 Grating Training System for Amblyopic Children

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1541632A (en) * 2003-09-27 2004-11-03 中国科学院长春光学精密机械与物理研 An intelligent amblyopia correction device
CN1579319A (en) * 2003-08-13 2005-02-16 王丽萍 Intelligent diagnosis and treatment instrument for infant's weak sight and strabism
CN101322666A (en) * 2008-07-28 2008-12-17 北京航空航天大学 Amblyopia training auxiliary treatment system and method
CN203154058U (en) * 2013-03-26 2013-08-28 河北路德医疗器械有限公司 Multifunctional amblyopia therapeutic equipment
CN109239952A (en) * 2018-10-08 2019-01-18 浙江工业大学 A kind of oppressive glasses system of intelligence amblyopia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384146B2 (en) * 2005-06-28 2008-06-10 Carestream Health, Inc. Health care kiosk having automated diagnostic eye examination and a fulfillment remedy based thereon
CN103439794B (en) * 2013-09-11 2017-01-25 百度在线网络技术(北京)有限公司 Calibration method for head-mounted device and head-mounted device
CN106236062B (en) * 2016-08-09 2019-10-29 浙江大学 A kind of police equipment of real-time monitoring policeman vital sign and field conditions on duty
CN107773248B (en) * 2017-09-30 2024-10-29 优视眼动科技(北京)有限公司 Eye movement instrument and image processing method
CN109271021B (en) * 2018-08-28 2021-11-09 北京七鑫易维信息技术有限公司 Method and device for controlling head-mounted device, head-mounted device and storage medium

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1579319A (en) * 2003-08-13 2005-02-16 王丽萍 Intelligent diagnosis and treatment instrument for infant's weak sight and strabism
CN1541632A (en) * 2003-09-27 2004-11-03 中国科学院长春光学精密机械与物理研 An intelligent amblyopia correction device
CN101322666A (en) * 2008-07-28 2008-12-17 北京航空航天大学 Amblyopia training auxiliary treatment system and method
CN203154058U (en) * 2013-03-26 2013-08-28 河北路德医疗器械有限公司 Multifunctional amblyopia therapeutic equipment
CN109239952A (en) * 2018-10-08 2019-01-18 浙江工业大学 A kind of oppressive glasses system of intelligence amblyopia

Also Published As

Publication number Publication date
CN111265392A (en) 2020-06-12

Similar Documents

Publication Publication Date Title
CN111265392B (en) Amblyopia treatment system
US11734896B2 (en) Augmented reality display system for evaluation and modification of neurological conditions, including visual processing and perception conditions
KR102669685B1 (en) Light field processor system
US7033025B2 (en) Interactive occlusion system
CN111202663B (en) Vision training learning system based on VR technique
US8770750B2 (en) Apparatus and method for establishing and/or improving binocular vision
CN107095733B (en) Amblyopia treatment system based on AR technology
JP2021502881A (en) Systems and methods for visual field analysis
CN201929941U (en) Hemispheric stimulating vision function diagnosis and treatment instrument
US20230380679A1 (en) Systems, methods, and devices for vision assessment and therapy
TW201545713A (en) Vision Protection Method and System Thereof
EP2358261A1 (en) Pupillary assessment method and apparatus
US20160128892A1 (en) Audio-feedback computerized system and method for operator-controlled eye exercise
CN106511044A (en) Amblyopia vision training system
CN102008286A (en) Hemispherical projection-based vision function diagnosing and treating system
US20220152339A1 (en) System and method for enhancing or rehabilitating the cognitive skills of a subject
CN116343987A (en) Personalized self-adaptive amblyopia training system and quantitative analysis and adjustment method thereof
Arnoldi Orthoptic evaluation and treatment
Ahmad THE SOUND OF SCOTOMA: A multisensory integration approach for individuals with Macular Degeneration
Purves Organization of the visual system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220701

Address after: 410300 rooms 327 and 328, phase I complex building, Changsha E center, No. 18 Xiangtai Road, Liuyang economic and Technological Development Zone, Changsha, Hunan Province

Patentee after: Hunan zhongjingkang Medical Technology Co.,Ltd.

Address before: 518000 Guangdong Shenzhen Baoan District Xixiang street, Po Yuen Road 168, excellent industrial products exhibition center A block 405

Patentee before: Shenzhen vision Intelligent Manufacturing Technology Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20240822

Address after: A405, Building A, Famous Procurement Center, Fishery Community, Xixiang Street, Bao'an District, Shenzhen City, Guangdong Province 518000

Patentee after: Shenzhen Zhongjingkang Medical Technology Co.,Ltd.

Country or region after: China

Address before: 410300 rooms 327 and 328, phase I complex building, Changsha E center, No. 18 Xiangtai Road, Liuyang economic and Technological Development Zone, Changsha, Hunan Province

Patentee before: Hunan zhongjingkang Medical Technology Co.,Ltd.

Country or region before: China

TR01 Transfer of patent right

Effective date of registration: 20250627

Address after: 543000 Guangxi Zhuang Autonomous Region Wuzhou City Wanxiu District Industrial Park Donghua Industrial Area A-5 Building 2nd Floor Room 201

Patentee after: Zhongjingkang (Guangxi) Medical Device Technology Co.,Ltd.

Country or region after: China

Address before: A405, Building A, Famous Procurement Center, Fishery Community, Xixiang Street, Bao'an District, Shenzhen City, Guangdong Province 518000

Patentee before: Shenzhen Zhongjingkang Medical Technology Co.,Ltd.

Country or region before: China